Company logo

PACB - Pacific Biosciences of California, Inc.

NASDAQ -> Healthcare -> Diagnostics & Research
Menlo Park, United States

PACB price evolution
PACB
(in millions $) 30 Sep 2021 30 Jun 2021 31 Mar 2021 31 Dec 2020
Current assets
Cash $425.89 $460.09 $933.23 $82.45
Short term investments $654.5 $684.58 $227.92 $237.2
Net receivables $23.95 $19.94 $12.91 $16.84
Inventory $18.28 $17.98 $16.27 $14.23
Total current assets $1129.81 $1189.14 $1195.95 $355.59
Long term investments $4.56 $3 $3.5 $3.5
Property, plant & equipment $76.98 $53.58 $53.37 $54.85
Goodwill & intangible assets $822.74
Total noncurrent assets $904.35 $56.65 $56.94 $58.39
Total investments $659.06 $687.58 $231.42 $240.7
Total assets $2034.15 $1245.78 $1252.89 $413.98
Current liabilities
Accounts payable $4.96 $4.76 $3.47 $3.58
Deferred revenue $28.22 $19.69 $15.29 $10.29
Short long term debt $7.13 $4.64 $4.45 $4.33
Total current liabilities $55.61 $45.43 $33.74 $38.5
Long term debt $945.87 $931.19 $932.16 $37.67
Total noncurrent liabilities $1137.74 $942.1 $938.6 $39.99
Total debt $953 $935.84 $936.61 $42
Total liabilities $1193.35 $987.54 $972.34 $78.49
Shareholders' equity
Retained earnings -$1148.76 -$1165.31 -$1124.3 -$1036.87
Other shareholder equity $0.03 -$0.01 $0.07 $0.09
Total shareholder equity $840.81 $258.25 $280.55 $335.49
(in millions $) 31 Dec 2020 31 Dec 2019 31 Dec 2018 31 Dec 2017
Current assets
Cash $82.45 $29.63 $18.84 $16.51
Short term investments $237.2 $19.47 $83.51 $46.37
Net receivables $16.84 $15.27 $8.6 $13.43
Inventory $14.23 $13.31 $17.88 $23.07
Total current assets $355.59 $81.05 $131.66 $101.62
Long term investments $3.5 $4 $4.5 $4.5
Property, plant & equipment $54.85 $62.9 $34.07 $37.92
Goodwill & intangible assets
Total noncurrent assets $58.39 $66.94 $38.62 $42.47
Total investments $240.7 $23.47 $88.01 $50.87
Total assets $413.98 $147.99 $170.28 $144.08
Current liabilities
Accounts payable $3.58 $8.37 $6.74 $9.09
Deferred revenue $10.29 $9.56 $7.43 $7.39
Short long term debt $4.33 $19.71
Total current liabilities $38.5 $49.15 $26.88 $28.64
Long term debt $37.67 $41.96 $14.66 $13.63
Total noncurrent liabilities $39.99 $43.91 $29.33 $29.35
Total debt $42 $61.67 $14.66 $13.63
Total liabilities $78.49 $93.07 $56.21 $57.98
Shareholders' equity
Retained earnings -$1036.87 -$1066.24 -$982.11 -$879.73
Other shareholder equity $0.09 $0.01 -$0.04 -$0.03
Total shareholder equity $335.49 $54.92 $114.06 $86.1
(in millions $) 30 Sep 2021 30 Jun 2021 31 Mar 2021 31 Dec 2020
Revenue
Total revenue $34.89 $30.61 $29 $27.14
Cost of revenue $19.52 $16.86 $16.02 $15.73
Gross Profit $15.36 $13.75 $12.98 $11.4
Operating activities
Research & development $27.51 $22.27 $20.55 $17.43
Selling, general & administrative $31.61 $29.06 $26.14 $17.95
Total operating expenses $89.84 $51.33 $46.69 $35.38
Operating income -$74.48 -$37.57 -$33.71 -$23.98
Income from continuing operations
EBIT -$74.61 -$37.41 -$85.65 $74.94
Income tax expense -$94.82
Interest expense $3.67 $3.59 $1.79
Net income
Net income $16.54 -$41 -$87.44 $74.94
Income (for common shares) $16.54 -$41 -$87.44 $74.94
(in millions $) 31 Dec 2020 31 Dec 2019 31 Dec 2018 31 Dec 2017
Revenue
Total revenue $78.89 $90.89 $78.63 $93.47
Cost of revenue $46.33 $56.31 $53.53 $58.81
Gross Profit $32.57 $34.58 $25.1 $34.66
Operating activities
Research & development $64.15 $59.63 $62.59 $65.32
Selling, general & administrative $72.8 $75.49 $63.49 $59.12
Total operating expenses $136.95 $135.12 $126.08 $124.44
Operating income -$104.39 -$100.55 -$100.99 -$89.78
Income from continuing operations
EBIT $29.67 -$81.52 -$100.14 -$89.27
Income tax expense
Interest expense $0.27 $2.61 $2.42 $2.92
Net income
Net income $29.4 -$84.13 -$102.56 -$92.19
Income (for common shares) $29.4 -$84.13 -$102.56 -$92.19
(in millions $) 30 Sep 2021 30 Jun 2021 31 Mar 2021 31 Dec 2020
Net income $16.54 -$41 -$87.44 $74.94
Operating activities
Depreciation $2.71 $2.39 $2.4 $2.35
Business acquisitions & disposals -$319.79
Stock-based compensation $28.45 $15.8 $10.16 $5.28
Total cash flows from operations -$40.66 -$15.71 -$23.1 -$14.26
Investing activities
Capital expenditures -$1.12 -$1.57 -$0.4 -$0.07
Investments $29.27 -$459.24 $8.57 -$98.43
Total cash flows from investing -$291.65 -$460.81 $8.17 -$98.5
Financing activities
Dividends paid
Sale and purchase of stock $299.9 $2.97 $22.1 $125.88
Net borrowings -$0.09 $895.62
Total cash flows from financing $299.66 $2.88 $865.72 $125.88
Effect of exchange rate
Change in cash and equivalents -$32.65 -$473.64 $850.79 $13.12
(in millions $) 31 Dec 2020 31 Dec 2019 31 Dec 2018 31 Dec 2017
Net income $29.4 -$84.13 -$102.56 -$92.19
Operating activities
Depreciation $9.3 $9.95 $7.21 $8.44
Business acquisitions & disposals
Stock-based compensation $17.53 $16.4 $23.15 $20.35
Total cash flows from operations $19.5 -$78.31 -$66.43 -$67.52
Investing activities
Capital expenditures -$1.04 -$2.84 -$1.85 -$10.39
Investments -$218.28 $64.88 -$36.56 $8.84
Total cash flows from investing -$219.32 $62.05 -$38.41 -$1.55
Financing activities
Dividends paid
Sale and purchase of stock $233.84 $8.55 $107.18 $73.31
Net borrowings -$16 -$4.5
Total cash flows from financing $251.84 $26.55 $107.18 $68.81
Effect of exchange rate
Change in cash and equivalents $52.02 $10.28 $2.34 -$0.26
Fundamentals
Market cap $2.26B
Enterprise value $2.79B
Shares outstanding 220.60M
Revenue $121.63M
EBITDA -$112.88M
EBIT -$122.73M
Net Income -$36.96M
Revenue Q/Q 82.83%
Revenue Y/Y 52.63%
P/E ratio -61.12
EV/Sales 22.91
EV/EBITDA -24.68
EV/EBIT -22.70
P/S ratio 18.57
P/B ratio 2.69
Book/Share 3.81
Cash/Share 1.93
EPS -$0.17
ROA -2.99%
ROE -8.62%
Debt/Equity 0.23
Net debt/EBITDA -6.80
Current ratio 20.32
Quick ratio 19.99